Key result
Exosomes derived from cardiac microvascular endothelial cells under high glucose conditions promoted cardiac fibroblast activation and aggravated cardiac fibrosis in mice via TGF-β1 mRNA.
Why the study?
Specific regulatory mechanisms governing cardiac fibroblast-mediated extracellular matrix remodeling in diabetic cardiomyopathy remain unclear, prompting investigation into how exosomes mediate interactions between cardiac microvascular endothelial cells and cardiac fibroblasts.
Population
Cardiac microvascular endothelial cells, cardiac fibroblasts, and mice treated with streptozotocin
Comparison
Exosomes derived from CMECs under high glucose conditions vs controls
Design
Preclinical in vitro and in vivo mechanistic study
Authors
Loading...
Suggests endothelial exosomes drive fibrosis in diabetic mouse hearts; leaves open clinical relevance and therapeutic targeting in humans.
Exosomes from cardiac microvascular endothelial cells under high glucose conditions mediate cardiac fibroblast activation via TGF-β1 mRNA, highlighting a novel mechanism and potential therapeutic target in diabetic cardiomyopathy.
Zhang et al. (2021) studied Diabetic cardiomyopathy. Exosomes derived from cardiac microvascular endothelial cells under high glucose conditions was evaluated on Cardiac fibroblast activation and perivascular/interstitial fibrosis. Exosomes derived from cardiac microvascular endothelial cells under high glucose conditions promoted cardiac fibroblast activation and aggravated cardiac fibrosis in mice via TGF-β1 mRNA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: